UpcomingCancerLungs & Breathing
New combination strategies to reduce side effects whilst maintaining immunotherapy efficacy in the treatment of non-small cell lung cancer
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by MRF at Queen Mary University of London.
View the original record at the funder ↗
Researchers
Kairbaan Hodivala-Dilke (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Strategies for optimised adjuvant immunotherapy following curative-intent radiotherapy or chemoradiotherapy for squamous cell cancer of the head and neck
Novel strategies to improve the effectiveness of radiation and targeted therapies in lung cancer
Turning cancer stem cells into endogenous vaccines
The role of low dose chemotherapy in sensitising the colon tumour microenvironment to immunotherapy
Overcoming tumour mediated immunosuppression using novel therapeutic agents; a strategy to reinvigorate anti-tumour immunity
Original classification
Impact of Cancer and Cancer Care on Human Biology and Health 2025Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.Is something wrong? Let us know